Lantern Pharma Inc. Common Stock

LTRNNASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
4.00 USD
↗ 0.11 (2.78%)🟢PRE MARKET (AS OF 07:01 AM EDT)
🟢Market: OPEN

Lantern Pharma Inc. Common Stock (LTRN) is currently trading at $4.00. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Furthermore, LTRN is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Jun 17, 2026.

Open?$3.97
High?$4.00
Low?$3.97
Prev. Close?$3.89
Volume?N/A
Avg. Volume?291.8K
Bid / Ask
Bid?$3.34 × 100
Ask?$4.66 × 100
Spread?$1.32
Midpoint?$4.00
Valuation & Ratios
Market Cap?49.6M
Shares Out?11.3M
Float?7.7M
Float %?68.5%
P/E Ratio?N/A
P/B Ratio?14.40
EPS?-$1.25
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
Themes
Healthcare - Oncology›Targeted Therapy & Precision OncologyAI & Machine Learning›AI-Powered Analytics & Decision Systems
Employees
16
Market Cap
49.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.lanternpharma.com
Listed
2020-06-11
Address
1920 MCKINNEY AVENUE
DALLAS, TX 75201
Phone: 972-277-1136
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
77
Short Sent.?
41
Piotroski F-Score?0/9Weak
Altman Z-Score?-17.86Distress
Confidence?41%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?19.29%High
Short Interest?1.5M
Days to Cover?5.8
Free Float7.7M
Avg Daily Volume256.9K
Settlement Date2026-05-29
Financial Health
Current Ratio?1.87Adequate
Quick Ratio?1.87Adequate
Cash Ratio?1.30Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
13
14.40HIGH▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.7CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-461.8%WEAK▾
ROA?
S&P
3
-220.3%WEAK▾
Cash Flow & Enterprise
FCF?$-15074553
Enterprise Value?$44.7M
Fundamentals ratios updated end of day
MarketsMoversWatchlist